| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/28/2009 | WO2009067081A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis |
| 05/28/2009 | WO2009066321A2 Process for optically active sulfoxide compounds |
| 05/28/2009 | WO2009066317A2 Process for the preparation of pantoprazole sodium |
| 05/28/2009 | WO2009066084A1 2 -morpholinopyrimidines and their use as pi3 kinase inhibitors |
| 05/28/2009 | WO2009048752A3 Insecticidal substituted azinyl derivatives |
| 05/28/2009 | WO2009048750A3 Insecticidal (1,3,5)-triazinyl phenyl hydrazones |
| 05/28/2009 | WO2009045313A3 Oxypiperidine derivatives as histamine receptor antagonists |
| 05/28/2009 | WO2008152086A3 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 05/28/2009 | WO2008093920A3 1,2-dihydro-1-oxophthalazinyl derivatives having biological activity on serotonin receptors 5-ht2a and 5-ht2c, and preparation thereof |
| 05/28/2009 | US20090137806 Dual nk1/nk3 receptor antagonists |
| 05/28/2009 | US20090137805 N-phenyl-2-pyrimidine-amine derivatives |
| 05/28/2009 | US20090137800 Novel compound, optical filter and optical recording material using the same |
| 05/28/2009 | US20090137635 Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
| 05/28/2009 | US20090137615 Indazolylamino quinazoline derivatives as antitumour agents |
| 05/28/2009 | US20090137611 Fungicide N-Cyclopropyl-Sulfonylamide Derivatives |
| 05/28/2009 | US20090137603 Heterocyclic amide compound and use thereof |
| 05/28/2009 | US20090137601 L-Phenylalanine Derivatives |
| 05/28/2009 | US20090137594 Pentafluorosulphanyl-Substituted Compound And Its Use For Producing Medicaments |
| 05/28/2009 | US20090137590 N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
| 05/28/2009 | US20090137588 Heteroaryl compounds and uses thereof |
| 05/28/2009 | US20090137587 4-[(4-Chlorobenzyl)oxy]-1-(4-[(1E)-3-(methylamino)-1-propen-1-yl]phenyl)pyridin-2(1H)-one; remedy for metabolic disorders such as obesity, diabetes, hormone disorder; cardiovascular disorders (stenocardia, acute or congestive heart failure); nervous system disorders (bulimia, anxiety, epilepsy etc.) |
| 05/28/2009 | US20090137576 Novel Piperidine Derivative |
| 05/28/2009 | US20090137570 Inhibitors of cathepsin s |
| 05/28/2009 | US20090137566 Substituted Piperdines as Renin Inhibitors |
| 05/28/2009 | US20090137560 Imidazole compounds having pharmaceutical activity towards the sigma receptor |
| 05/28/2009 | US20090137558 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
| 05/28/2009 | US20090137498 Substituted benzene derivatives or salts thereof |
| 05/28/2009 | US20090137457 Pyrimidinedione derivatives |
| 05/28/2009 | US20090137021 Anti-inflammatory medicaments |
| 05/28/2009 | US20090136596 P38 inhibitors and methods of use thereof |
| 05/28/2009 | US20090136473 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | US20090134784 Carbazole-containing materials in phosphorescent light emitting diodes |
| 05/28/2009 | US20090134780 Electron transport material and organic electroluminescent device using the same |
| 05/28/2009 | US20090133318 Anthranilamide insecticides |
| 05/28/2009 | CA2722611A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | CA2722582A1 Biaryl pde4 inhibitors for treating inflammation |
| 05/28/2009 | CA2706328A1 Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor |
| 05/28/2009 | CA2705834A1 Non-nucleoside reverse transcriptase inhibitors |
| 05/28/2009 | CA2704214A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis |
| 05/27/2009 | EP2062914A2 Somatostatin-dopamine chimeric analogs |
| 05/27/2009 | EP2062887A1 Novel aminopyridine derivative having aurora a-selective inhibitory activity |
| 05/27/2009 | EP2062886A1 Salt of phenoxypyridine derivative or crystal thereof and process for producing the same |
| 05/27/2009 | EP2062885A1 Acid addition salts of imatinib and formulations comprising the same |
| 05/27/2009 | EP2062879A1 Heterocyclic inhibitors of p38 |
| 05/27/2009 | EP2062583A2 Therapeutic applications of pro-apoptotic benzodiazepines |
| 05/27/2009 | EP2061786A2 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase |
| 05/27/2009 | EP2061785A2 Linear pyridazine and pyrrole compounds, processes for obtaining them and uses |
| 05/27/2009 | EP2061784A1 2-benzimidazolyl-6-morpholino-4-phenylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 05/27/2009 | EP2061783A2 Improved process for rimonabant |
| 05/27/2009 | EP2061782A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 05/27/2009 | EP2061781A1 Substituted 1-(azolin-2-yl)-amino-1,2-heterocyclyl-ethane compounds for combating pests |
| 05/27/2009 | EP2061780A1 Diaryl piperidine compounds as calcium channel blockers |
| 05/27/2009 | EP2061779A1 Aryl sulfonamides with an analgesic action |
| 05/27/2009 | EP2061774A2 Arylpiperazine derivatives and uses thereof |
| 05/27/2009 | EP2061773A2 Quinazoline based egfr inhibitors containing a zinc binding moiety |
| 05/27/2009 | EP2061770A1 Piperazine compounds with herbicidal action |
| 05/27/2009 | EP2061768A2 Imidazole-4,5-dicarboxamide derivatives as jak-2 modulators |
| 05/27/2009 | EP2061765A2 Serine-threonine protein kinase and parp modulators |
| 05/27/2009 | EP2061763A2 Process for the preparation of substituted-1,2,3,4-tetrahydroisoquinoline derivates |
| 05/27/2009 | EP2061762A2 Pyrazine compounds, their use and methods of preparation |
| 05/27/2009 | EP2061761A1 Phenethylamide derivatives with kinase inhibitory activity |
| 05/27/2009 | EP2061756A2 2-aminocarbonylphenylamino-2-phenilacetamides as factor viia inhibitors useful as anticoagulants |
| 05/27/2009 | EP1981874B1 Aminophenyl derivatives as novel inhibitors of histone deacetylase |
| 05/27/2009 | EP1912706A4 Novel 5-substituted indole derivatives as dipeptidyl peptidase iv (dpp-iv) inhibitors |
| 05/27/2009 | EP1866286B1 Pyridine derivatives useful as inhibitors of pkc-theta |
| 05/27/2009 | EP1725544B1 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| 05/27/2009 | EP1663241B1 5-arylpyrimidines as anticancer agents |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP1487797B1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors |
| 05/27/2009 | EP1404666B1 4-substituted-picolinic acid amide derivatives useful as fungicides |
| 05/27/2009 | EP1250140B1 Combination ofan abl-, pdgf-receptor- and/or kit receptor-tyrosine kinase inhibitor with an organic compound capable of binding to alpha1-acidic glycoprotein |
| 05/27/2009 | EP1171424B1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 05/27/2009 | CN101443327A Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof |
| 05/27/2009 | CN101443326A Substituted prolinamides, production thereof and their use as drugs |
| 05/27/2009 | CN101443325A 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors |
| 05/27/2009 | CN101443324A Benzylamine derivatives as CETP inhibitors |
| 05/27/2009 | CN101443323A Substituted spirocyclic CGRP receptor antagonists |
| 05/27/2009 | CN101443322A Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 05/27/2009 | CN101443318A Heterobicyclic carboxamides as inhibitors for kinases |
| 05/27/2009 | CN101443316A 1,5-diphenylpyrazoles II as HSP90 inhibitors |
| 05/27/2009 | CN101443314A Aminoquinolones as GSK-3 inhibitors |
| 05/27/2009 | CN101443309A IAP BIR domain binding compounds |
| 05/27/2009 | CN101443006A Novel benzylamine derivatives as CETP inhibitors |
| 05/27/2009 | CN101440085A Thrombin inhibitors containing guanidine heterocyclic compound and preparation thereof |
| 05/27/2009 | CN101440062A Synthesis of N-acyl-8-amino quinoline derivatives and use thereof as fluorescent molecular probe |
| 05/27/2009 | CN101440059A 4-substituted 2,2'-bipyridyl derivatives and synthesizing method thereof |
| 05/27/2009 | CN100491372C Substituted quinazoline derivatives as inhibitors of aurora kinases |
| 05/27/2009 | CN100491371C Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
| 05/27/2009 | CN100491359C 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators |
| 05/27/2009 | CN100491355C Cyclic diamine compound having five-membered cyclic group |
| 05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 05/27/2009 | CN100491352C Asymmetrical cyclic diamine compound |
| 05/27/2009 | CN100491351C Polymeric charge transport compositions and electronic devices made with such compositions |
| 05/27/2009 | CN100491349C Antiviral agent |
| 05/27/2009 | CN100491348C Thrombosis resisting preparation |
| 05/26/2009 | US7538231 Tyrosine kinase inhibitors |
| 05/26/2009 | US7538225 Producing bridged erythromycin derivative intermediates; oximination of 2-chloro-5-chloromethyl-pyridine followed by reaction with pyrazole under acid catalyst conditions and optional hydrolysis |
| 05/26/2009 | US7538223 Compounds, compositions and methods |
| 05/26/2009 | US7538222 Such as N-{1-[2-(1,3-dioxan-2-yl)ethyl]piperidin-4-yl}-N-(4-fluorobenzyl)-2-[4-(2-hydroxy-2-methylpropoxy)phenyl]acetamide; selective inverse agonists of 5-HT2A receptor with minimal monamine receptors subtype activity; antipsychotics with reduced side effects |
| 05/26/2009 | US7538221 Polymorphs of racemic, dextrorotatory, and levorotatory enantioners of 1-cyclopropyl-6-fluoro-8-methoxy-7-(4-amino-3,3-dimethylpiperidin-1-yl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid hydrochloride and mesylate salts |